Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

January 26, 2024 12:34 (London Time)

Vaxart

Youtube Subscribe

...

Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.9686
MarketCap: 124,460,717.0
High: 0.84 Low: 0.8

Open: 0.81 Close: 0.82 Change: 0.01

Our AI found 5 flaws in Vaxart Company Inc Stock.

How much time have you spent trying to decide whether investing in Vaxart? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Vaxart are: Vaxart, BARDA, …

Concept Map

...

Semantic Network

...

Stock Summary

Vaxart, Inc. engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase.

Today's Summary

Vaxart, Inc. (Nasdaq: SGMT) soared 170% on Monday after the biopharmaceutical company announced… Funds from BARDA will support preparations for the trial.

Today's News

Vaxart awarded $9.27 million from barda project nextgen to prepare for late-stage study of oral pill covid-19 vaccine candidate. Funds from BARDA will support preparations for the trial. Vaxart, Inc. (Nasdaq: VXRT) awarded $9.27 million by the United States Biomedical Advanced Research and Development Authority (BARDA) to fund preparation for a 10,000 subject Phase 2b clinical study evaluating Vaxarts oral pill XBB COVID-19 vaccine candidate. Vaxart, Inc. (Nasdaq: SGMT) soared 170% on Monday after the biopharmaceutical company announced… Vaxarts wins BARDA Grant for Oral Covid 19 Vaccine Candidate Study January 22, 2024 at 4:42 pm Clinical stage biotechnology company, VaxART, Inc., won.

Stock Profile

"Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase II clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine, an oral vaccine platform, which is in preclinical stage; coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection; human papillomavirus therapeutic vaccine that targets HPV 16 and HPV 18 for cervical cancers and precancerous cervical dysplasia. The company has license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California."

Keywords

Are looking for the most relevant information about Vaxart? Investor spend a lot of time searching for information to make investment decisions in Vaxart. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Vaxart are: Vaxart, BARDA, Inc, award, study, oral, pill, and the most common words in the summary are: vaxart, best, stock, vaccine, inc, trial, news, . One of the sentences in the summary was: Vaxart, Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #vaxart #best #stock #vaccine #inc #trial #news.

Read more →

Related Results

...
March 01, 2024 0:44 (London Time)

Vaxart

Vaxart, Inc. (vaxrt) worth $187 mil (down $-12 mil), still more valuable than /*err: invalid ticker symbol. Only non-blank, uppercase tickers suppor…
Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.2944
MarketCap: 199,431,693.0
High: 1.31 Low: 1.21

Open: 1.29 Close: 1.22 Change: -0.07

Read more →
...
May 31, 2023 1:08 (London Time)

Vaxart

Vaxart Inc. (VXRT) has 135,597,316 shares trading at $1.20 per share. The total value of the stock is $162.72M. The market value is measured differe…
Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.9716
MarketCap: 118,484,934.0
High: 1.35 Low: 1.18

Open: 1.25 Close: 1.23 Change: -0.02

Read more →
...
January 26, 2024 12:34 (London Time)

Vaxart

Vaxart, Inc. (Nasdaq: SGMT) soared 170% on Monday after the biopharmaceutical company announced… Funds from BARDA will support preparations for the …
Sector: Biotechnology
Ticker: VXRT
Sentiment: 0.9686
MarketCap: 124,460,717.0
High: 0.84 Low: 0.8

Open: 0.81 Close: 0.82 Change: 0.01

Read more →